IPO SnapShot

INDO US BIO-TECH LTD.

IPODATE
Apr 30, 2018 TO May 03, 2018
LISTINGDATE
5/11/2018 12:00:00 AM
APPLY NOW
FACEVALUE
₹ 10

per share

ISSUESIZE
₹ 7.293 Cr
PRICEBAND
₹ 51

per share

MARKETLOT
2000

shares

OBJECTIVE

1. To meet Incremental Working Capital Requirement 2. General Corporate Purpose 3. Meeting Public Issue Expenses.

DON'T HAVE A DEMAT ACCOUNT

OPENDEMAT ACCOUNTAND START YOURINVESTMENTJOURNEY WITH US

OPEN AN ACCOUNT (You will receive a call & SMS from our end)
BUSINESS DESCRIPTION

Our Company was originally incorporated as ?Pollucid Bio-Tech Private Limited? at Junagadh on February 4, 2004,under the provisions of the Companies Act, 1956 vide Certificate of Incorporation issued by the Assistant Registrar ofCompanies, Gujarat, Dadra and Nagar Haveli. Subsequently, the name of our company was change to ?Pellucid Bio-Tech Private Limited? and the fresh Certificate of Incorpo...

ADDRESS

Address: 309
Shanti Mall
Satadhar Char Rasta
Opp. Navrang Tower
Sola Road
City: Ahmedabad,
State: Gujarat
Pincode: 380061
Phone: 079 2749 1807 / 9909043999
Email: indousexim@gmail.com
Website: www.indousagriseeds.com

LISTED AT

BSE

LEAD MANAGER

Swastika Investmart Ltd.

PROMOTERS

Jagdish Ajudia

PROMOTER'S HOLDING

Total Share Capital

3424352

Offered to Public

1430000

Promoter's Holding (Pre-Issue)

100

Promoter's Holding (Post-Issue)

70.54
REGISTRAR

Bigshare Services Pvt Ltd
G 10 Left Wing Amruta Village
Opp: Yashoda Hospital
Raj Bhavan Road
Somajiguda
Hyderabad

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.